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confirmed the initial reports but none of these studies used a control group.
Later authors (Goodwin, 1967 ; Linton and Ham, 1967 ; Gallant et al., 1968; Gelder and Edwards, 2968; Merry and Westhead, 1968) failed to confIrm the early findings, in trials of short term prognosis, of somatic and psychic effects of metronidazole-alcohol interaction. Lal ( 1969) reviewed the literature and reported a single-blind trial of two treatment groups and a control group which also failed to show any positive effect from metronidazole.
The majority of the studies quoted above were carried out over short periods of time, often of two months or less. Whilst this is legitimate in research into the alleged antabuse like action of metronidazole, it is not a long enough period to study the effect of any factor on the prognosis of alcoholism. Davies, Shepherd and Myers (1956) , in a two year follow-up of hospitalized alcoholics, found that the prog Patients who failed treatment in the first week were excluded from the trial. This rarely happened, since all patients were started on the medication whilst they were in-patients. Three patients, however, did so, and so the final number on the short term trial, up to four weeks, was 57.
i. Short term trial

LONG TERM TRIAL OF METRONIDAZOLE IN MALE ALCOHOLICS
and were excluded from the long term trial. Only two of these patients were taking metroni dazole and both had had short stay in-patient care; of the other five patients twâ€¢had short stay care and three prolonged group psycho therapy.
Long term trial
Thirty-two patients progressed to the long term trial, i8 in the metronidazole group and 14 in the control group.
TAFI.E II
Six mont/is assessment
TAFI.E I N Score at four weeks
The trend noticed at the end of the short-term trial was again evident, but the difference in the ratings of the metronidazole group com pared with the placebo group just failed to reach statistical significance.
At twelve months the trend was even more marked, and the final assessment showed met ronidazole to be associated with a good prognosis significantly more often than placebo (Table III) . design, lasted for too short a period, ten weeks and twelve weeks respectively, to be of value. In neither of these studies was there found to be any difference between the active prepara tion and placebo groups. the two preparations to be equally effective up to six months, but neither treatment was considered to be any more effective than the usual regime of treatmentâ€"about which no detailwas given.A similarstudy on alcoholics living in a hostel was carried out by Merry x2 = 6@246o (Yates' correction) p < @O25
TAF1.@ III
In order not to influence the patient's expect ancy of the effects of tablets too greatly each patient was told that he might expect to feel less like drinking alcohol when taking the medication than he had done previously.
The investigator did not ask directly about the effects of the medication, but the side-effects spontaneously reported were as follows: In the long term trial the patients who improved with metronidazole complained of side-effects more often than those who did not improve with the drug, although this trend was not statistically significant (Table VI) . As Gelder and Edwards pointed out, it is probable that the â€˜¿ side effects' are the main effects of the drug in relation to its success in treating alcoholism. 
SUMMARY
A long-term double blind trial of metronida zole in alcoholism is described. In the short term trial, up to four weeks, there was a trend to greater improvement in the metronidazole group, but this trend only reached statistically significant levels (p<o 025) at twelve month follow-up.
Possible methods of action of the drug are discussed. Differences in the random selection of patients for the two groups could have been responsible for the differences in treatment outcome. No statistically significant differences were found between the short-term/long-term: metronida zole/placebo groups. The Straus-Bacon Score
